Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Reports (MQSA)

Reports (MQSA) Home
          Radiation-Emitting Products
          Mammography Quality Standards Act and Program
          Reports (MQSA)
          Mammography Facility Adverse Event and Action Report – April 25, 2023:  University Park OBGYN, LLCReports (MQSA) Mammography Facility Adverse Event and Action Report – April 25, 2023:  University Park OBGYN, LLC
  
  	
    Share
    Post
    Linkedin

    Email
    PrintStatus of the Facility

University Park OBGYN, LLC has a Mammography Quality Standards Act (MQSA) certificate in effect, is currently accredited and may provide mammography services.

Facility

University Park OBGYN, LLC
2401 University Parkway, Suite 201
Sarasota, FL 34243

Facility ID Number

248181

Inspection/Reporting Entity

U.S. Food and Drug Administration (FDA)

Actions Taken by the FDA

On July 19, 2022, the facility’s accreditation body, the American College of Radiology (ACR), initiated an Additional Mammography Review (AMR) of mammograms performed at the facility from April 29, 2022, through July 19, 2022, based on the clinical image quality deficiencies noted during the facility’s initial accreditation process.

On August 24, 2022, the ACR notified the facility that it failed the AMR. Six (6) out of the thirty (30) clinical cases submitted did not meet the ACR’s clinical image evaluation criteria; some of the deficiencies were severe. Additionally, the ACR notified the facility that it intended to revoke its accreditation. The facility did not appeal the adverse accreditation decision and the ACR revoked the facility’s accreditation, effective on September 8, 2022.

Based on the information obtained from the ACR concerning the reasons for the revocation of the facility’s accreditation, the FDA determined that the facility’s practice posed a serious risk to human health, and that in order to protect the public health, on September 9, 2022, declared the facility’s MQSA certificate to be no longer in effect until such time as the facility’s accreditation is reinstated and the facility has complied with all the requirements of the FDA. The FDA required the facility to perform a Patient and Referring Healthcare Provider Notification (PPN) to alert patients who had mammograms performed at this facility from April 29, 2022, through September 9, 2022, and their referring health care providers of the mammography quality problems at the facility.

Corrective Action

The facility successfully completed the PPN and was notified of such by the FDA on November 23, 2022. The facility successfully completed an ACR corrective action plan. The ACR reinstated the facility’s accreditation, and on April 11, 2023, the FDA issued an MQSA certificate to the facility so that it could legally perform mammography.

Background - MQSA Program

The FDA compiles and makes available to physicians and the general public information that is useful in evaluating the performance of mammography facilities. As of October 2010, the FDA posts individual notices following completion of the adverse actions taken against facilities. This information is useful in evaluating the performance of mammography facilities nationwide and assists providers and patients in making informed decisions. For additional information, please see the Reports (MQSA) webpage.

Additional Resources

For more information, please refer to the MQSA Program http://www.fda.gov/mammography webpage. Annual and semi-annual reports issued prior to October 2010 can be found on the Document Archives (MQSA) webpage.

                                                                                  Content current as of:
      04/25/2023
              
              
Regulated Product(s)
		 Radiation-Emitting ProductsReports (MQSA)
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop